Stakeholder perspectives on addressing adverse events from adjuvant cancer therapy: A qualitative study.
Syril D PettitPamela SilbermanKristen Hassmiller LichRebecca A KirchSteven E LipshultzRandall TealEthan BaschPublished in: Cancer (2019)
Despite commonalities in the overall needs identified by the diverse stakeholders in the current study, broad systemic change has been stymied. The current study identified the lack of alignment and the absence of a central "owner" of these diffuse efforts as a previously unrecognized hurdle to realizing the desired systemic improvements. Future initiatives aimed at improving quality of life and outcomes for patients receiving adjuvant therapy through the improved use of AE information must address this challenge through innovative collectives and novel leadership strategies.